Suchergebnisse - "Watson, Birgit"

PubPharm (11)

1

A Pharmacokinetic Dose-Optimization Study of Cabotegravir and Bictegravir in a Mouse Pregnancy Model

enthalten in: Pharmaceutics | 2022

von Mohan, H. | Atkinson, K. | Watson, B. | +2

2

Untimed Efavirenz Drug Levels After Switching From Brand to Generic Formulations : A Short Communication

enthalten in: Therapeutic drug monitoring | 2021

von Watson, B. | Atkinson, K. | Auyeung, K. | +6

3

Oral administration of tipranavir with long-chain triglyceride results in moderate intestinal lymph targeting but no efficient delivery to HIV-1 reservoir in mesenteric lymph nodes

enthalten in: International journal of pharmaceutics | 2021

von Chu, Y. | Qin, C. | Feng, W. | +9

4

Improving the clinical relevance of a mouse pregnancy model of antiretroviral toxicity; a pharmacokinetic dosing-optimization study of current HIV antiretroviral regimens

enthalten in: Antiviral research | 2018

von Kala, S. | Watson, B. | Zhang, J. | +6

5

HIV treatment simplification to elvitegravir/cobicistat/emtricitabine/tenofovir disproxil fumarate (E/C/F/TDF) plus darunavir : a pharmacokinetic study

enthalten in: AIDS research and therapy | 2017

von Harris, M. | Ganase, B. | Watson, B. | +3

6

HIV treatment simplification to elvitegravir/cobicistat/emtricitabine/tenofovir disproxil fumarate (E/C/F/TDF) plus darunavir: a pharmacokinetic study

enthalten in: AIDS research and therapy | 2017

von Harris, M. | Ganase, B. | Watson, B. | +3

7

HIV treatment simplification to elvitegravir/cobicistat/emtricitabine/tenofovir disproxil fumarate (E/C/F/TDF) plus darunavir: a pharmacokinetic study

enthalten in: AIDS research and therapy | 2017

von Harris, M. | Ganase, B. | Watson, B. | +3

8

Efficacy and safety of "unboosting" atazanavir in a randomized controlled trial among HIV-infected patients receiving tenofovir DF

enthalten in: HIV clinical trials | 2017

von Harris, M. | Ganase, B. | Watson, B. | +5

9

Efficacy and safety of “unboosting” atazanavir in a randomized controlled trial among HIV-infected patients receiving tenofovir DF

enthalten in: HIV clinical trials | 2017

von Harris, M. | Ganase, B. | Watson, B. | +5

10

Efficacy and safety of “unboosting” atazanavir in a randomized controlled trial among HIV-infected patients receiving tenofovir DF

enthalten in: HIV clinical trials | 2017

von Harris, M. | Ganase, B. | Watson, B. | +5